Cell therapy market
Cell Therapy Market, By Therapy Type (Stem Cells, T-cells, Dendritic Cells, NK-cells), By Indication (Oncology, Cardiology, Neurology, Others), By End User (Hospitals, Clinics, Research Institutes), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
- Apr 2024
- CMI5413
- 168 Pages
- Excel & Pdf
- Biotechnology
Summary
N/A
Table of Content
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Therapy Type
- Market Snapshot, By Indication
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Regulatory Scenario
- Technological Advancements
- Manufacturer Revenue
- Acquisitions and Partnerships Scenario
- Product Launches/Approvals
- Fundings and Investments
- PEST Analysis
- Porter’s Analysis
- Market Dynamics
- Global Cell Therapy Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the market
- Global Cell Therapy Market, By Therapy Type, 2019 – 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Stem Cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- T-cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Dendritic Cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- NK-cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Overview
- Global Cell Therapy Market, By Indication, 2019 – 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Cardiology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Neurology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Overview
- Global Cell Therapy Market, By End User, 2019 – 2031, (USD Mn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
- Overview
- Global Cell Therapy Market, By Region, 2019 – 2031, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019–2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Mn)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Bristol Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Gilead Sciences, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Johnson & Johnson Services, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Allogene Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Athersys, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Orchard Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- JW Therapeutics Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Dendreon Pharmaceuticals LLC.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Autolus Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- APAC Biotech
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- CORESTEM, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BioCardia, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- JCR Pharmaceuticals Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Oxford Biomedica
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- CASI Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Financial Performance
- Bristol Myers Squibb Company
- Company Profiles
- Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
- References and Research Methodology
- References
- Research Methodology
Segmentation
Detailed Segmentation-
- By Therapy Type:
- Stem Cells
- T-cells
- Dendritic Cells
- NK-cells
- By Indication:
- Oncology
- Cardiology
- Neurology
- Others
- By End User:
- Hospitals
- Clinics
- Research Institutes
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Frequently Asked Questions -
What is the CAGR of global cell therapy market during the forecast period?
The CAGR of global cell therapy market is projected to be 9.4% from 2024 to 2031.
What are the major factors driving the global cell therapy market growth?
Technological advancement for development of cell therapy and increasing number of regulatory approvals for cell therapy products are the major factor driving the growth of global cell therapy market.
What are the key factors hampering growth of the global cell therapy market?
High cost of cell therapies and stringent regulatory frameworks are the major factor hampering the growth of global cell therapy market.
Which is the leading therapy type segment in the global cell therapy market?
In terms of therapy type, T-cells segment is estimated to dominate the market in 2024.
Which are the major players operating in the global cell therapy market?
Bristol Myers Squibb Company, Amgen Inc., Novartis AG, Gilead Sciences, Inc., Johnson & Johnson Services, Inc., Allogene Therapeutics, Athersys, Inc., Orchard Therapeutics, JW Therapeutics Co., Ltd., Dendreon Pharmaceuticals LLC., Autolus Therapeutics, APAC Biotech, CORESTEM, Inc., BioCardia, Inc., JCR Pharmaceuticals Co., Ltd., Oxford Biomedica, CASI Pharmaceuticals Inc. are the major players.
Which region will lead the global cell therapy market?
North America is expected to lead the global cell therapy market.